Verification evidence is still being completed.
PDF / print export
Cerbios-Pharma SA
Barbengo, Switzerland
- Verified lead
- Emanuela Malacrida
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- HPAPI Manufacturing, Antibody-Drug Conjugates, and Recombinant Protein CDMO
- Review cycle
- 24 April 2026
- Full address
- Via Figino 6, 6917 Barbengo, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Moneyhouse Swiss commercial registry entry for Cerbios-Pharma SA.
- Editorial note
- Ticino-based pharmaceutical CDMO with named CEO, HPAPI, ADC, and recombinant protein manufacturing scope, and a more than forty-year pharma track record.
HPAPI Manufacturing, Antibody-Drug Conjugates, and Recombinant Protein CDMO
Swiss commercial registry record, Swiss Biotech Association listing, GMP pharmaceutical CDMO
Ticino-based pharmaceutical CDMO with named CEO, HPAPI, ADC, and recombinant protein manufacturing scope, and a more than forty-year pharma track record.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Barbengo, Switzerland
Cerbios-Pharma SA
HPAPI Manufacturing, Antibody-Drug Conjugates, and Recombinant Protein CDMO · Commercial pharmaceutical CDMO manufacturing
Ticino-based pharmaceutical CDMO with named CEO, HPAPI, ADC, and recombinant protein manufacturing scope, and a more than forty-year pharma track record.
- Lead
- Emanuela Malacrida (verified ↗)
- Address
- Via Figino 6, 6917 Barbengo, Switzerland (source ↗)
- Compliance
- GMP pharmaceutical CDMO
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Commercial pharmaceutical CDMO manufacturing
- Capabilities
- HPAPI Manufacturing · Antibody-Drug Conjugate CDMO Services · Recombinant Protein Production
- Founded
- 1976
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Emanuela Malacrida
Chief Executive Officer
Full addressVia Figino 6, 6917 Barbengo, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
CPHI Online company profile listing Cerbios-Pharma SA at Via Figino 6, Barbengo.
Open sourceCommercial pharmaceutical CDMO manufacturing
Barbengo, Switzerland. HPAPI Manufacturing, Antibody-Drug Conjugates, and Recombinant Protein CDMO. Review completed on 24 Apr 2026.
Swissmedic, FDA, and EMA for CDMO manufacturing oversight
Swiss commercial registry record, Swiss Biotech Association listing, GMP pharmaceutical CDMO
HPAPI Manufacturing, Antibody-Drug Conjugates, and Recombinant Protein CDMO
Ticino-based pharmaceutical CDMO with named CEO, HPAPI, ADC, and recombinant protein manufacturing scope, and a more than forty-year pharma track record.
Editorial note
Cerbios-Pharma is a Ticino-based CDMO focused on HPAPI, ADC, and recombinant protein manufacturing, with a named CEO recorded in the Swiss commercial registry and a long-standing industry presence since 1976.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
HPAPI Manufacturing
Antibody-Drug Conjugate CDMO Services
Recombinant Protein Production
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
HPAPI manufacturing suites
ADC conjugation chemistry
Recombinant protein production
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Cerbios-Pharma SA located?
- Cerbios-Pharma SA operates from Via Figino 6, 6917 Barbengo, Switzerland, Barbengo, Switzerland.
- Who runs Cerbios-Pharma SA?
- Cerbios-Pharma SA is led by Emanuela Malacrida, Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does Cerbios-Pharma SA hold?
- Cerbios-Pharma SA is documented under GMP pharmaceutical CDMO.
- What does Cerbios-Pharma SA do?
- Ticino-based pharmaceutical CDMO with named CEO, HPAPI, ADC, and recombinant protein manufacturing scope, and a more than forty-year pharma track record. Core capabilities: HPAPI Manufacturing, Antibody-Drug Conjugate CDMO Services, Recombinant Protein Production.
Editorial context
Related technical briefs
Briefs that name Barbengo as a covered market or city.